Literature DB >> 28777789

Corrigendum: Is autoimmunity the Achilles' heel of cancer immunotherapy?

Carl H June, Jeremy T Warshauer, Jeffrey A Bluestone.   

Abstract

Entities:  

Year:  2017        PMID： 28777789     DOI： 10.1038/nm0817-1004b

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  When worlds collide: Th17 and Treg cells in cancer and autoimmunity.

Authors:  Hannah M Knochelmann; Connor J Dwyer; Stefanie R Bailey; Sierra M Amaya; Dirk M Elston; Joni M Mazza-McCrann; Chrystal M Paulos
Journal:  Cell Mol Immunol       Date:  2018-03-21       Impact factor: 11.530

2.  Endocrine immune-related adverse events: a double-edged sword?

Authors:  Michelle Rengarajan; Justin F Gainor
Journal:  Transl Lung Cancer Res       Date:  2021-01

Review 3.  Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature.

Authors:  Víctor Albarrán; Jesús Chamorro; Diana Isabel Rosero; Cristina Saavedra; Ainara Soria; Alfredo Carrato; Pablo Gajate
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

Review 4.  PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases.

Authors:  Ke Zhang; Xiangyi Kong; Yuan Li; Zhongzhao Wang; Lin Zhang; Lixue Xuan
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.